PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 396.0
(0.51%)
IDR 396.0
(0.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7094.31 Billion IDR | 19.03% |
| 2022 | 5960.21 Billion IDR | -18.08% |
| 2021 | 7275.45 Billion IDR | 11.74% |
| 2020 | 6510.95 Billion IDR | -6.13% |
| 2019 | 6936.38 Billion IDR | 233.55% |
| 2018 | 2079.59 Billion IDR | 101.93% |
| 2017 | 1029.87 Billion IDR | 489.46% |
| 2016 | 174.71 Billion IDR | 228.15% |
| 2015 | -136.33 Billion IDR | 42.46% |
| 2014 | -236.95 Billion IDR | 30.95% |
| 2013 | -343.16 Billion IDR | -18.89% |
| 2012 | -288.64 Billion IDR | -65.31% |
| 2011 | -174.61 Billion IDR | 19.69% |
| 2010 | -217.41 Billion IDR | -127.4% |
| 2009 | -95.6 Billion IDR | -33.59% |
| 2008 | -71.56 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 7042.15 Billion IDR | -1.57% |
| 2024 Q3 | 7153.85 Billion IDR | 0.17% |
| 2024 Q1 | 7154.19 Billion IDR | 0.84% |
| 2023 FY | 7094.31 Billion IDR | 19.03% |
| 2023 Q4 | 7094.31 Billion IDR | -1.6% |
| 2023 Q3 | 7209.99 Billion IDR | 0.46% |
| 2023 Q2 | 7176.75 Billion IDR | 11.92% |
| 2023 Q1 | 6412.5 Billion IDR | 7.59% |
| 2022 Q1 | 7548.69 Billion IDR | 3.76% |
| 2022 Q4 | 5960.21 Billion IDR | -26.86% |
| 2022 FY | 5960.21 Billion IDR | -18.08% |
| 2022 Q2 | 8184.35 Billion IDR | 8.42% |
| 2022 Q3 | 8149.3 Billion IDR | -0.43% |
| 2021 Q2 | 7396.33 Billion IDR | 4.1% |
| 2021 FY | 7275.45 Billion IDR | 11.74% |
| 2021 Q1 | 7105.26 Billion IDR | 9.13% |
| 2021 Q4 | 7275.45 Billion IDR | -5.12% |
| 2021 Q3 | 7668.36 Billion IDR | 3.68% |
| 2020 Q4 | 6510.95 Billion IDR | -13.27% |
| 2020 FY | 6510.95 Billion IDR | -6.13% |
| 2020 Q3 | 7506.87 Billion IDR | 0.83% |
| 2020 Q2 | 7445.21 Billion IDR | 2.91% |
| 2020 Q1 | 7234.81 Billion IDR | 4.3% |
| 2019 Q4 | 6936.38 Billion IDR | -1.91% |
| 2019 FY | 6936.38 Billion IDR | 233.55% |
| 2019 Q1 | 5764 Billion IDR | 177.17% |
| 2019 Q2 | 6437.57 Billion IDR | 11.69% |
| 2019 Q3 | 7071.14 Billion IDR | 9.84% |
| 2018 Q2 | 2224.86 Billion IDR | 26.4% |
| 2018 FY | 2079.59 Billion IDR | 101.93% |
| 2018 Q1 | 1760.21 Billion IDR | 70.92% |
| 2018 Q4 | 2079.59 Billion IDR | -26.01% |
| 2018 Q3 | 2810.67 Billion IDR | 26.33% |
| 2017 Q3 | 1268.01 Billion IDR | 33.08% |
| 2017 Q2 | 952.84 Billion IDR | 53.16% |
| 2017 Q1 | 622.14 Billion IDR | 256.09% |
| 2017 FY | 1029.87 Billion IDR | 489.46% |
| 2017 Q4 | 1029.87 Billion IDR | -18.78% |
| 2016 Q3 | 506.76 Billion IDR | 43.01% |
| 2016 Q4 | 174.71 Billion IDR | -65.52% |
| 2016 Q1 | 162.43 Billion IDR | 219.15% |
| 2016 Q2 | 354.35 Billion IDR | 118.14% |
| 2016 FY | 174.71 Billion IDR | 228.15% |
| 2015 Q2 | 156.27 Billion IDR | 281.22% |
| 2015 Q1 | -86.23 Billion IDR | 63.61% |
| 2015 FY | -136.33 Billion IDR | 42.46% |
| 2015 Q3 | 241.68 Billion IDR | 54.66% |
| 2015 Q4 | -136.33 Billion IDR | -156.41% |
| 2014 Q4 | -236.95 Billion IDR | -250.75% |
| 2014 Q3 | 157.18 Billion IDR | 11.02% |
| 2014 Q2 | 141.57 Billion IDR | 168.8% |
| 2014 Q1 | -205.78 Billion IDR | 40.03% |
| 2014 FY | -236.95 Billion IDR | 30.95% |
| 2013 Q2 | -77.3 Billion IDR | 55.77% |
| 2013 Q4 | -343.16 Billion IDR | -1215.95% |
| 2013 FY | -343.16 Billion IDR | -18.89% |
| 2013 Q3 | -26.07 Billion IDR | 66.26% |
| 2013 Q1 | -174.75 Billion IDR | 39.46% |
| 2012 Q3 | -62.44 Billion IDR | -17.25% |
| 2012 Q4 | -288.64 Billion IDR | -362.22% |
| 2012 Q1 | -178.74 Billion IDR | -2.37% |
| 2012 FY | -288.64 Billion IDR | -65.31% |
| 2012 Q2 | -53.26 Billion IDR | 70.2% |
| 2011 FY | -174.61 Billion IDR | 19.69% |
| 2011 Q4 | -174.61 Billion IDR | 0.0% |
| 2010 FY | -217.41 Billion IDR | -127.4% |
| 2009 FY | -95.6 Billion IDR | -33.59% |
| 2008 FY | -71.56 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | -683.1 Billion IDR | 1138.536% |
| PT Itama Ranoraya Tbk | 148.83 Billion IDR | -4666.666% |
| PT Millennium Pharmacon International Tbk | 651.43 Billion IDR | -989.026% |
| PT Soho Global Health Tbk | -668.51 Billion IDR | 1161.198% |